# Takeda invests $230M expanding plasma-derived therapies capacity in Los Angeles

Takeda announced a $230 million investment to expand production capacity for plasma-derived therapies at its Los Angeles manufacturing site, creating over 125 new long-term jobs.

- Type: Expansion
- Announced: 2024-06-11
- Where: Los Angeles, California, United States
- Value: $230.0M
- Jobs: 125
- Status: announced
- Products: plasma-derived therapies
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Takeda](https://endata.com/companies/52956.md)

## Sources

- [takeda.com](https://www.takeda.com/en-us/newsroom/news-releases/2024/expanding-production-capacity-for-pdt-at-la-manufacturing-site/), 2024-06-11: "We are pleased to make this investment at our LA site, demonstrating our commitment to our manufacturing footprint in the U.S."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.